Atlas Trials

Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC

Clinical trial NCT03348969 · COMPLETED

Trial details

NCT number
NCT03348969
Sponsor
Jørgen Bjerggaard Jensen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2017-11-01
Primary completion
2019-06-11
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.